ZIRPRIME

K111383 · Noritake Co., Inc. · EIH · Aug 12, 2011 · Dental

Device Facts

Record IDK111383
Device NameZIRPRIME
ApplicantNoritake Co., Inc.
Product CodeEIH · Dental
Decision DateAug 12, 2011
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.6660
Device ClassClass 2

Intended Use

Zirprime is intended for CAD/CAM fabrication of zirconia frameworks for all-ceramic dental restorations.

Device Story

Zirprime is a zirconia-based material used for the fabrication of dental frameworks. It is processed via CAD/CAM systems to create all-ceramic dental restorations. The device is intended for use by dental professionals in a clinical or laboratory setting. The material provides the structural framework for crowns, bridges, or other dental prosthetics, which are then finished and placed by a dentist to restore patient dental function and aesthetics.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Zirconia-based material for CAD/CAM dental framework fabrication. Class II device under 21 CFR 872.6660 (Porcelain Powder for Clinical use).

Indications for Use

Indicated for CAD/CAM fabrication of zirconia frameworks for all-ceramic dental restorations in patients requiring dental prosthetics.

Regulatory Classification

Identification

Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows a logo for the Department of Health & Human Services. The logo features a stylized eagle with three lines representing its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES" is arranged in a circular pattern around the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MID 20993-0002 Noritake Company, Incorporated C/O Mr. Ivan J. Wasserman Partner Manatt, Phelps & Phillips, LLP 700 12th Street NW Suite 1100 Washington DC 20005 AUG 1 2 2011 Re: K111383 Trade/Device Name: Zirprime Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder for Clinical use Regulatory Class: II Product Code: EIH Dated: May 16, 2011 Received: May 17, 2011 Dear Mr. Wasserman: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Page 2- Mr. Wasserman Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm 115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely vours. Wh for Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - . | 510(k) Number (if known): | K111383 | |---------------------------|----------| | Device Name: | Zirprime | | Indications For Use: | | Zirprime is intended for CAD/CAM fabrication of zirconia frameworks for all-ceramic dental restorations. | Prescription Use<br>(Part 21 CFR 801 Subpart D) | <span style="text-decoration: overline;">✓</span> | AND/OR | Over-The-Counter Use<br>(21 CFR 801 Subpart C) | | |-------------------------------------------------|---------------------------------------------------|--------|------------------------------------------------|--| |-------------------------------------------------|---------------------------------------------------|--------|------------------------------------------------|--| (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) ![Signature](signature.png) | (Division Sign-Off) | | |-----------------------------------------------------------------------------------|-----------| | Division of Anesthesiology, General Hospital<br>Infection Control, Dental Devices | Page 1 of | | 510(k) Number: | 12111383 | . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%